Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011860 (
type 2 diabetes
)
57,723
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Zinc
is required for normal immune function and taste acuity and enhances the in vitro effectiveness of insulin. Impaired immune function and taste have been reported in diabetic subjects, and decreased serum
zinc
levels and hyperzincuria occur in some diabetic subjects and animals. Subjects with type II diabetes were examined to determine whether the similar effects of
zinc
depletion and diabetes are causally related. Low serum
zinc
levels were found in 16 of 180 subjects (9 percent). There was no correlation between serum
zinc
and glycosylated hemoglobin levels. Natural killer cell activity did not differ between diabetic subjects (n = 28) and control subjects (n = 38) and did not correlate with serum
zinc
levels. T lymphocyte response to phytohemagglutinin was lower in diabetic subjects than in control subjects (70 +/- 10 versus 103 +/- 7 X 10(3) counts per minute) but was not lowest in those with the lowest
zinc
levels. Taste thresholds for hydrochloric acid, sucrose, sodium chloride, and urea were elevated in diabetic subjects (n = 28) versus control subjects (n = 10), but thresholds did not correlate with glycosylated hemoglobin or serum
zinc
levels.
Zinc
supplementation in nine diabetic subjects had no effect on the glycosylated hemoglobin level, natural killer cell activity, or taste thresholds, but it did increase mitogen activity in those with the lowest initial phytohemagglutinin responses. It is concluded that
zinc
deficiency occurs in a subset of subjects with type II diabetes but is not related to diabetes control and does not explain decreased taste acuity. Zinc deficiency may play a role in abnormal immune function in
type II diabetes mellitus
.
...
PMID:Role of zinc supplementation in type II diabetes mellitus. 372 55
Fasting plasma
zinc
levels were determined in 45 IDDM and in 40
NIDDM
patients. Mean values were similar in both groups, but diabetic men showed a significantly higher plasma
zinc
(p less than 0.05) than diabetic women. In patients with diabetic nephropathy a lower
zinc
level was associated with decreased plasma albumin as compared to patients without complications (p less than 0.001). Neuropathy and macro-angiopathy were also associated with lower zincemia (p less than 0.05) but in the presence of normal albumin levels. In IDDM without nephropathy a significant positive correlation was found between plasma
zinc
and plasma glucose, albumin, branched chain amino acids and glutamine, while in
NIDDM
without nephropathy a significant positive correlation exists between plasma
zinc
and the amino acids glutamine, valine, histidine and lysine.
...
PMID:Plasma zinc levels in diabetes mellitus: relation to plasma albumin and amino acids. 375 14
Zinc
metabolism in 20 patients with stable
type II diabetes mellitus
was investigated. Twenty-five percent of these patients had depressed serum
zinc
concentrations, and all demonstrated hyperzincuria. Urinary
zinc
loss was greater when proteinuria was present and correlated with the mean serum glucose concentration. Studies of gastrointestinal
zinc
absorption suggested
zinc
malabsorption in patients with
type II diabetes mellitus
. Glucose infusion in normal dogs produced hyperzincuria without a diminution in serum
zinc
. It is concluded that hyperzincuria, resulting from a glucose-mediated process that is not osmotic, interacts with impaired
zinc
absorption to produce
zinc
deficiency in patients with
type II diabetes mellitus
.
...
PMID:Abnormal zinc metabolism in type II diabetes mellitus. 688 Nov 79
Zinc
status was assessed in patients with
type II diabetes mellitus
and congestive heart failure (CHF). Three groups of patients were enrolled into the study: Group 1: 15 patients with
type II diabetes mellitus
and CHF; Group 2: 20 patients with isolated
type II diabetes mellitus
; and Group 3: nine patients with isolated CHF. Twenty-four-hour urine was measured for creatinine, protein, and
zinc
, and blood was drawn for creatinine, proteins, liver enzymes, hemoglobin A1c, and
zinc
. Insulin treatment and hemoglobin A1c were comparable in the diabetic patients of groups 1 and 2, but group 1 was also treated with captopril and diuretics like the CHF patients of group 3. Plasma
zinc
levels were statistically similar in all three groups, but urinary
zinc
excretion (mumol/24 h) and urinary
zinc
: creatinine (mumol/mmol) ratio were significantly higher in the type II diabetics and CHF group (27.2 +/- 1.5; 1.69 +/- 0.6, respectively) compared to the diabetic patients alone (19.4 +/- 0.76; 0.97 +/- 0.3, respectively) and the CHF patients (9.7 +/- 0.3; 0.62 +/- 0.3, respectively). and the CHF patients (9.7 +/- 0.3; 0.62 +/- 0.3, respectively). Patients with
type II diabetes mellitus
and CHF were treated with higher doses of captopril than the CHF patients (56.25 +/- 24 mg vs 18.8 +/- 11 mg P < 0.05). Thus, patients with
type II diabetes mellitus
and CHF excrete larger amounts of
zinc
, which may eventually lead to
zinc
deficiency.
...
PMID:Type II diabetes mellitus, congestive heart failure, and zinc metabolism. 750 74
In order to investigate the relationships between metals
zinc
[Zn], copper [Cu], magnesium [Mg], or Calcium [Ca] and noninsulin-dependent diabetes mellitus, 65 patients of newly diagnosed noninsulin-dependent diabetes mellitus and 54 nondiabetic healthy controls were studied. The concentrations of selected metals in fasting blood samples and 24-h urine collections were determined. Hyperzincuria and hypermagnesuria were detected in diabetic patients (p < 0.01). The diabetics also had lower Zn and Mg, and higher Cu, and Ca levels in their plasma than those of the controls, but the statistical differences in Ca and Mg were not significant. Significantly lower Zn and higher Ca levels in erythrocytes were found in diabetic patients (p < 0.01). There is evidence of a significant difference in metals status between diabetic patients with or without the specific complications. This study further indicates that patients with
NIDDM
on Taiwan also have distinct changes in their metals status, and these perturbations are associated with some diabetic complications.
...
PMID:Selected metals status in patients with noninsulin-dependent diabetes mellitus. 860 79
Non-insulin-dependent diabetes mellitus
(
NIDDM
) may cause vulnerability to moderate
zinc
deficiency. In this study, short-term
zinc
supplementation (30 mg/d as amino acid chelate for 3 wk) elevated plasma
zinc
and activities of 5'-nucleotidase, a
zinc
-dependant enzyme, in 20 postmenopausal women with
NIDDM
. Placebo, given to 20 other women with
NIDDM
, had no effects on these indexes nor on any others taken in this study. Although
zinc
supplementation doubled the mean value for 5'-nucleotidase activity, values were still significantly lower than those of age-matched control subjects. Plasma insulin-like growth factor I concentrations increased with
zinc
treatment if starting concentrations were < 165 microg/L but were unchanged if they were > 165 microg/L. Lipoprotein oxidation in vitro, which has abnormal lag times and propagation rates for subjects with
NIDDM
and for moderately
zinc
-deficient rats, were unchanged by
zinc
supplementation. Possibly, this lack of effect occurred because the
zinc
treatment did not normalize
zinc
status. In conclusion, this study supports the contention that moderate
zinc
deficiency occurs frequently in subjects with
NIDDM
.
...
PMID:Short-term zinc supplementation in women with non-insulin-dependent diabetes mellitus: effects on plasma 5'-nucleotidase activities, insulin-like growth factor I concentrations, and lipoprotein oxidation rates in vitro. 949 98
Low plasma
zinc
concentrations and increased
zinc
excretion have been reported in patients with
non-insulin dependent diabetes mellitus
(
NIDDM
). This study was designed to compare
zinc
metabolism in ten
NIDDM
patients with ten healthy controls, using stable isotopes of
zinc
.
Zinc
absorption from a standard breakfast labelled extrinsically with 3 mg 67Zn was measured using a fecal monitoring technique and thermal ionization quadrupole mass spectrometry. One hour after the test meal each volunteer was given 0.5 mg 70Zn (as citrate) intravenously and blood samples taken at intervals for up to 6 days. Isotopic enrichment was measured and the data entered into a simple kinetic model to estimate the size and rate of turnover of exchangeable pools of
zinc
. Urinary
zinc
excretion was higher in the male diabetics than controls (p < 0.05), but not in females. Since the efficiency of absorption and endogenous losses of
zinc
were very variable between individuals, and there was only a limited amount of data, it was not possible to draw conclusion about the effect of
NIDDM
on
zinc
absorption and excretion. However, the fact that there were no differences in exchangeable
zinc
pool sizes suggests that
zinc
metabolism is not altered in
NIDDM
.
...
PMID:Zinc metabolism in non-insulin dependent diabetes mellitus. 928 85
The concentration of copper (Cu) and
zinc
(Zn) in hair and urine were studied in young nonpregnant healthy women whose both parents were diagnosed for noninsulin-dependent diabetes mellitus (
NIDDM
descendants) and were compared with those of young healthy nonpregnant females with no family history of
NIDDM
or hypertension (non-
NIDDM
descendants) and
NIDDM
patients. The concentration of Zn in hair in
NIDDM
descendants was significantly higher than that of non-
NIDDM
descendants (p < 0.001) and insignificantly higher than that of
NIDDM
patients. The hair Cu concentrations in
NIDDM
descendant and patients were significantly lower than that of non-
NIDDM
descendants (p < 0.001). Hyperzincuria was detected in some
NIDDM
patients and hypocuperuria in all
NIDDM
descendants and patients. The data suggest that the young healthy
NIDDM
descendants possess high-Zn and low-Cu reserves in their bodies, and the observed perturbation appears to be associated with Cu-Zn antagonism.
...
PMID:Assessment of copper and zinc status in hair and urine of young women descendants of NIDDM parents. 967 87
The hair
zinc
content in 16 patients with metabolic X syndrome (mzX) was measured by means of atomic absorption spectrometry method. The mean concentration (125.13 mg/kg) was lower than in the majority of other published studies. The differences among groups of patients with different sex or diseases (e.g. coronary heart disease, hypertension,
type II diabetes mellitus
) were not significant. It seems to be probably that deficiency of
zinc
plays a role in pathogenesis of mzX or that it is a consequence of mzX.
...
PMID:[Low zinc levels in metabolic X syndrome (mzX) patients measured by hair zinc composition analysis]. 984 83
Zinc
concentrations in leukocytes of healthy subjects and patients with
NIDDM
were determined by inductively coupled plasma mass spectrometry. Lymphocytes and granulocytes were isolated from whole blood by discontinuous gradients of mono-poly resolving medium and flow cytometry. Flow cytometry was used for isolating lymphocytes and granulocytes from mononuclear and polymorphonuclear leukocytes. The results in healthy subjects and patients with
NIDDM
were as follows: lymphocytes of healthy male and female subjects were 49.8 +/- 1.0 (mean +/- SE, microgram per 10(10) cells) and 50.0 +/- 1.4, respectively; granulocytes were 46.4 +/- 1.0 in male, 49.3 +/- 1.4 in female. Lymphocytes of male and female patients with
NIDDM
were 43.3 +/- 0.9 and 43.1 +/- 1.7, respectively; granulocytes, 41.2 +/- 1.4 in male, 43.8 +/- 1.0 in female. There was a significant difference in the
zinc
concentrations of lymphocytes and granulocytes between healthy subjects and patients with
NIDDM
. However, there was no significant difference in the
zinc
concentrations of lymphocytes and granulocytes between male and female. In healthy subjects,
zinc
concentrations of lymphocytes and granulocytes significantly lowered with aging.
...
PMID:[Analysis of zinc concentrations in leukocytes and its application to patients with non-insulin-dependent diabetes mellitus]. 1003 15
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>